Showing results (91-100 of 347) with videos related to

Sort By:
Pageof 35
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 29, 2002
Optimal strategies for modeling the reciprocal of creatinine versus time in renal transplant recipients and patients with native chronic renal diseaseJeffrey C Fink, Steven A Blahut, Matthew R Weir
Current Opinion in Nephrology and Hypertension|July 14, 2009
Drug interactions in transplant patients: what everyone should knowWana Manitpisitkul, Erin McCann, Sabrina Lee, et al.
P & T : a Peer-Reviewed Journal for Formulary Management|February 9, 2010
Thiazolidinediones and cardiovascular events in high-risk patients with type-2 diabetes mellitus: a comparison with other oral antidiabetic agentsFadia T Shaya, Zhiqiang Lu, Kyongsei Sohn, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 23, 2019
Hypertension in CKD: Core Curriculum 2019Elaine Ku, Benjamin J Lee, Jenny Wei, et al.
Clinical Nephrology|June 25, 2024
Clinical management of unremitting nephrogenic diabetes insipidusNasha Elavia, Matthew R Weir, Abdolreza Haririan, et al.
Current Opinion in Nephrology and Hypertension|December 20, 2007
The balance of angiotensin II and nitric oxide in kidney diseasesPrabhleen Singh, Aihua Deng, Matthew R Weir, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|September 30, 2010
Effects of high- and low-sodium diets on ambulatory blood pressure in patients with hypertension receiving aliskirenMatthew R Weir, Anthony M Yadao, Das Purkayastha, et al.
Drugs - Real World Outcomes|May 21, 2021
Safety and Tolerability of the Potassium Binder Patiromer From a Global Pharmacovigilance Database Collected Over 4 Years Compared with Data from the Clinical Trial ProgramPatrick Rossignol, Lea David, Christine Chan, et al.
American Heart Journal|October 18, 2003
Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development programMatthew R Weir, Rhoda S Sperling, Alise Reicin, et al.
Current Medical Research and Opinion|May 3, 2014
Effect of canagliflozin on serum electrolytes in patients with type 2 diabetes in relation to estimated glomerular filtration rate (eGFR)Matthew R Weir, Irina Kline, John Xie, et al.
Pageof 35